Intuitive Surgical Inc. (ISRG) Scheduled to Post Earnings on Tuesday
Intuitive Surgical Inc. (NASDAQ:ISRG) is set to post its quarterly earnings results on Tuesday, October 18th. Individual that wish to register for the company’s earnings conference call can do so using this link.
Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, July 19th. The company reported $5.62 EPS for the quarter, beating analysts’ consensus estimates of $4.97 by $0.65. Intuitive Surgical had a net margin of 26.80% and a return on equity of 15.25%. The company earned $670 million during the quarter, compared to the consensus estimate of $640.69 million. During the same quarter last year, the firm posted $4.57 EPS. On average, analysts expect Intuitive Surgical to post $21.30 EPS for the current fiscal year and $24.20 EPS for the next fiscal year.
Intuitive Surgical Inc. (NASDAQ:ISRG) opened at 714.91 on Monday. Intuitive Surgical Inc. has a 12 month low of $467.36 and a 12 month high of $727.25. The company has a market cap of $27.52 billion, a P/E ratio of 40.57 and a beta of 0.72. The stock has a 50 day moving average of $701.42 and a 200-day moving average of $663.84.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/17/intuitive-surgical-inc-isrg-scheduled-to-post-earnings-on-tuesday.html
A number of equities research analysts have recently commented on the stock. Piper Jaffray Cos. reaffirmed a “neutral” rating and issued a $700.00 price objective (up from $610.00) on shares of Intuitive Surgical in a research note on Wednesday, July 20th. Barclays PLC boosted their target price on shares of Intuitive Surgical from $690.00 to $750.00 and gave the company an “overweight” rating in a research report on Wednesday, July 20th. Zacks Investment Research downgraded shares of Intuitive Surgical from a “hold” rating to a “sell” rating in a research report on Monday, June 27th. Northland Securities downgraded shares of Intuitive Surgical from a “market perform” rating to an “under perform” rating and set a $600.00 target price on the stock. in a research report on Thursday, July 21st. Finally, Canaccord Genuity boosted their target price on shares of Intuitive Surgical from $700.00 to $750.00 and gave the company a “buy” rating in a research report on Wednesday, July 20th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and fourteen have issued a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $701.42.
In related news, SVP Mark J. Meltzer sold 3,000 shares of the stock in a transaction dated Monday, August 22nd. The shares were sold at an average price of $688.33, for a total transaction of $2,064,990.00. Following the completion of the transaction, the senior vice president now owns 2,331 shares in the company, valued at $1,604,497.23. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Gary S. Guthart sold 13,400 shares of the stock in a transaction dated Monday, August 1st. The shares were sold at an average price of $698.00, for a total transaction of $9,353,200.00. Following the transaction, the chief executive officer now owns 78,780 shares of the company’s stock, valued at approximately $54,988,440. The disclosure for this sale can be found here. Corporate insiders own 3.10% of the company’s stock.
Institutional investors have recently bought and sold shares of the stock. FMR LLC raised its position in shares of Intuitive Surgical by 15.5% in the second quarter. FMR LLC now owns 2,190,718 shares of the company’s stock worth $1,448,962,000 after buying an additional 294,511 shares in the last quarter. TIAA CREF Investment Management LLC raised its position in shares of Intuitive Surgical by 9.0% in the second quarter. TIAA CREF Investment Management LLC now owns 567,759 shares of the company’s stock worth $375,521,000 after buying an additional 46,762 shares in the last quarter. Winslow Capital Management LLC raised its position in shares of Intuitive Surgical by 3.4% in the second quarter. Winslow Capital Management LLC now owns 477,114 shares of the company’s stock worth $315,567,000 after buying an additional 15,480 shares in the last quarter. American Century Companies Inc. raised its position in shares of Intuitive Surgical by 0.7% in the second quarter. American Century Companies Inc. now owns 415,307 shares of the company’s stock worth $274,688,000 after buying an additional 2,854 shares in the last quarter. Finally, BlackRock Group LTD raised its position in shares of Intuitive Surgical by 2.5% in the second quarter. BlackRock Group LTD now owns 303,704 shares of the company’s stock worth $200,874,000 after buying an additional 7,455 shares in the last quarter. Institutional investors own 91.90% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.